课题基金 / 基金详情

Phosphorylation of Human Thyroid Hormone Receptor beta-1 by Casein Kinase II

Phosphorylation of Human Thyroid Hormone Receptor beta-1 by Casein Kinase II
酪蛋白激酶 II 磷酸化人甲状腺激素受体 beta-1
批准号:
09671018
负责人:
SUGAWARA Akira
金额:
$1.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

SUGAWARA Akira的其他基金

相似基金

相关文献

中文摘要
翻译
细菌表达的人甲状腺激素受体β 1(hTR β 1)在体外可被HeLa细胞胞质提取物磷酸化。在本研究中,我们首次证明了hTR β 1也可以在体外被纯化的酪蛋白激酶II(CKII)B磷酸化。磷酸化氨基酸分析显示hTrbeta 1在丝氨酸和苏氨酸残基上都被磷酸化。体外CKII磷酸化谷胱甘肽S-转移酶(GST)-hTR β 1融合蛋白,其预测的CKII磷酸化位点突变表明,位于铰链区(Thr-210)的苏氨酸残基可以被CKII磷酸化。为了阐明CKf 1磷酸化Thr-210在hTR β 1中的功能意义,我们用野生型和Thr-210突变型hTR β 1进行瞬时转染研究。有趣的是,当使用Thr-210突变型hTR β 1时,在缺乏配体的情况下基础抑制显著减弱。由于Thr-210位于与核受体辅阻遏物(N-CoR)相互作用的结构域内,我们接下来进行电泳迁移率移位测定(EMSA)以检查氨基末端截短的N-CoR(NCoRI)与野生型或Thr-210突变的hTR β 1之间的相互作用。有趣的是,与同样与两种类型的hTR β 1形成异源二聚体的类维生素A OMEGA受体β(RXR β)相反,N CoRIp与野生型hTR β 1形成异源二聚体,而不是Thr-210突变的hTR β 1。综上所述,我们推测Thr-210 m hTR β 1的CKII磷酸化可能调节与N-Co R的相互作用,并在配体缺乏的情况下介导基础抑制。
英文摘要
Bacterially-expressed human thyroid hormone receptor beta-1 (hTRbeta1) recently has been shown to be phosphorylated in vitro by HeLa cytoso1ic extract. In the present study, we first demonstrated that hTRbeta1 also could be phosphorylated in vitro b purified casein kinase II (CKII). Phosphoamino acid analysis revealed hTrbeta1 was phosphorylated on both serine and threonine residues. In vitro CKII phosphorylation of glutathione S-transferase (GST)-hTRbeta1 fusion proteins whose predicted CKII phosphorylation sites were mutated demonstrated that a threonine residue located in the hinge region(Thr-210) could be phosphorylated by CKII. In order to elucidate the functional significance of CKfl phosphorylation of Thr-210 in hTRbeta1, we next performed transient transfection studies using either wild type or Thr-210 mutated hTRbeta1.In terestingly, the basal repression eve in the absence of ligand was attenuated significantly when Thr-210 mutated hTRbeta1 was used. Since Thr-210 is located within the interacting domain with nudear receptor co-repressor (N-CoR), we next performed electrophoretic mobility shifi assay (EMSA)to examine the interaction between amino terminal-truncated N-CoR (NCoRI) and wild type or Thr-210 mutated hTRbeta1. Interestingly, in contrast to retinoid OMEGA receptor beta(RXRbeta) which equally formed heterodimers with both types of hTR beta1, N CoRIp referentially formed heterodimers with wild type hTRbeta1 than Thr-210mutated hTRbeta1. Taken together, we speculate that CKII phosphorylation ofThr-210 m hTRbeta1 might modulate interaction with N-Co R, and contribute tomediate basal repression in the absence of ligand.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
菅原 明、他: "ヒトβ1型甲状腺ホルモン受容体 (hTRβ1) のカゼインキナーゼII (CKII) によるリン酸化メカニズムの解明" 診療と新薬. 第36巻第7号 未定. (1999)
Akira Sukawara 等人:“通过酪蛋白激酶 II (CKII) 阐明人 β1 甲状腺激素受体 (hTRβ1) 的磷酸化机制”,《医学实践与新药》第 36 卷,第 7 期,TBA。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
菅原 明、他: "ヒトβ1型甲状腺ホルモン受容体(hTRβ1)のカゼインキナーゼII (CKII)によるリン酸化メカニズムの解明" 診療と新薬. 第36巻 第7号. (1999)
Akira Sukawara 等人:“通过酪蛋白激酶 II (CKII) 阐明人 β1 甲状腺激素受体 (hTRβ1) 的磷酸化机制”,《医学实践与新药》,第 36 卷,第 7 期(1999 年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Innovation of a novel anti-hypertensive therapy due to the inhibitionof aldosterone synthase (CYP11B2) gene expression
  • 批准号:
    22591006
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2010
  • 负责人:
    SUGAWARA Akira
  • 依托单位:
EFFECTS OF ALL-TRANS RETINOIC ACID AND RETINOIDS ON ANGIOGENESIS
  • 批准号:
    18591015
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.43万
  • 财政年份:
    2006
  • 负责人:
    SUGAWARA Akira
  • 依托单位:
Effect of co-activator proteins on peroxisome proliferator-activated receptor (PPAR-γ-mediated gene transcription in vascular smooth muscle cells
  • 批准号:
    14571058
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.24万
  • 财政年份:
    2002
  • 负责人:
    SUGAWARA Akira
  • 依托单位:
Significance and molecular mechanisms of natriuretic peptide family in the protection from renal dysfunction
  • 批准号:
    11671066
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $1.92万
  • 财政年份:
    1999
  • 负责人:
    SUGAWARA Akira
  • 依托单位:
国内基金
海外基金
Succinate-Succinate Receptor介导的代谢反应在正畸牙根吸收中的作用
  • 批准号:
    82371007
  • 项目类别:
    面上项目
  • 资助金额:
    48万元
  • 批准年份:
    2023
  • 负责人:
    雷浪
  • 依托单位:
Leptin receptor阳性细胞通过分泌Hedgehog蛋白调控椎间盘退变及修复的谱系研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    傅强
  • 依托单位:
丹参酮ⅡA通过靶向TRAIL-receptor和ULBPs增强NK细胞抗非小细胞肺癌效应的作用及分子机制研究
  • 批准号:
    81903932
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2019
  • 负责人:
    龚陈媛
  • 依托单位:
白介素-1受体相关激酶(Interleukin-1 receptor associated kinase,IRAK)-M调节哮喘气道炎症异质性和气道重塑以及相关机制的研究